CN Patent

CN119074659A — 一种氟马西尼鼻喷剂及其制备方法和其应用

Assigned to Academy of Military Medical Sciences AMMS of PLA · Expires 2024-12-06 · 1y expired

What this patent protects

本发明涉及一种氟马西尼鼻喷雾剂，以质量体积比计，所述鼻喷雾剂中含有氟马西尼0.1‑1％，苯甲醇1‑20％、丙二醇0‑20％和聚乙二醇400 0‑20％。本发明科学筛选并优化氟马西尼鼻喷剂的组分及配比，有效解决的氟马西尼溶解难题，提高了制剂的稳定性。本发明的氟马西尼鼻喷剂具有安全有效、生物利用度高、使用便捷、成本更优、用药经济、患者依从性好等优点。

USPTO Abstract

本发明涉及一种氟马西尼鼻喷雾剂，以质量体积比计，所述鼻喷雾剂中含有氟马西尼0.1‑1％，苯甲醇1‑20％、丙二醇0‑20％和聚乙二醇400 0‑20％。本发明科学筛选并优化氟马西尼鼻喷剂的组分及配比，有效解决的氟马西尼溶解难题，提高了制剂的稳定性。本发明的氟马西尼鼻喷剂具有安全有效、生物利用度高、使用便捷、成本更优、用药经济、患者依从性好等优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN119074659A
Jurisdiction
CN
Classification
—
Expires
2024-12-06
Drug substance claim
No
Drug product claim
No
Assignee
Academy of Military Medical Sciences AMMS of PLA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.